Longitudinal Analysis Of Patents On Colorectal Cancer
DOI:
https://doi.org/10.31686/ijier.vol7.iss11.1966Keywords:
patents, colorectal cancer, technological advancesAbstract
Colorectal cancer is epidemiologically relevant worldwide because it is the fourth leading cause of death from cancer. This study aims to present the mapping of technologies related to colorectal cancer. The search took place during the months of May and June 2019. The Leans database was used, which collects global patent information. The search occurred through the term "colorectal cancer", inserted in the title or abstract fields. Patents with publication date between January 1, 2000 and June 1, 2019 were selected. Only the patents granted and those filed were filtered (patent application; granted patent). A total of 6,850 patents were identified, of which 5,445 (79.48%) correspond to patents filed and 1,405 (20.51%) are patents granted in the period from 2000 to 2019. In 2000, 47 patents on colorectal cancer were published. The quantitative growth of technologies filed and granted was constant. In 2017 there was a total of 911 applications, indicating a growth of 1938.29% in relation to the year 2000. The first patent of the period was on the APC gene mutation, associated with colorectal cancer in families of Ashkenazi Jews, developed by Laken and collaborators (2000), and belongs to Johns Hopkins University, Baltimore, Maryland, in the United States. It can be concluded that the mapping of patents is important to trace a panorama of the world technological advance, as well as it can also be used as an instrument to identify scientific articles that cite patents developed in a given time space.
Downloads
References
[2] ANTUNES, A. M. S.; PARREIRAS, V. M. A.; QUINTELLA, C. M.; RIBEIRO, N. M. “Métodos de Prospecção Tecnológica, Inteligência Competitiva e Foresight: principais conceitos e técnicas”. I. In: Núbia Moura. Prospecção Tecnológica. Salvador, BA, Brasil: Editora do Instituto Federal da Bahia (EDIFBA), 2018, 1, p.19-108 p.
[3] ARNOLD, M.; SIERRA, M. S.; LAVERSANNE, M.; SOERJOMATARAM, I.; JEMAL, A.; BRAY, F. “Global patterns and trends in colorectal cancer incidence and mortality”. Gut, v.1, p.1-9, 2016.
[4] BOYLE, Peter; LEON, Maria Elena. “Epidemiology of colorectal cancer”. British medical bulletin, v. 64, n. 1, p. 1-25, 2002.
[5] BOUVARD, Véronique et al. “ Carcinogenicity of consumption of red and processed meat”. The Lancet Oncology, v. 16, n. 16, p. 1599-1600, 2015.
[6] BRASIL. Ministério da Saúde. Instituto Nacional do Câncer. Falando sobre câncer do intestino: orientações úteis aos usuários fatores de riscos e proteção. 1ª ed. Rio de Janeiro (RJ): INCA; 2003.
[7] CAMPOS, F. G. C. M.; FIGUEIREDO, M. N.; MONTEIRO, M.; NAHAS, S. C.; CECCONELLO, I. “Incidence of colorectal cancer in young patients”. Revista do Colégio Brasileiro de Cirurgiões, v.44, p.208-221, 2017.
[8] CENTER, Melissa M.; JEMAL, Ahmedin; WARD, “Elizabeth. International trends in colorectal cancer incidence rates”. Cancer Epidemiology and Prevention Biomarkers, v. 18, n. 6, p. 1688-1694, 2009.
[9] FAGUNDES, M.C.; GARCIA, P.A.A.; MOTTA, G.S.; ARMOND-DE-MELO, D.R. “Perfil Tecnológico da Csn: Um Estudo Patentométrico”. Revista da Administração e Inovação, v. 11, n.1, p.276-294, jan./mar. 2014.
[10] FEDIRKO, V. et al. “Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies”. Annals of oncology, v. 22, n. 9, p. 1958-1972, 2011.
[11[ FERLAY, Jacques et al. “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012”. European journal of cancer, v. 49, n. 6, p. 1374-1403, 2013.
[12] GASPARINI, Brenda et al. “Análise do efeito idade-período-coorte na mortalidade por câncer colorretal no Estado do Rio de Janeiro, Brasil, no período 1980 a 2014”. Cad. Saúde Pública, Rio de Janeiro, v. 34, n. 3, e00038017, 2018.
[13] HARRISS, D. J. et al. “Lifestyle factors and colorectal cancer risk (1): systematic review and meta‐analysis of associations with body mass index”. Colorectal disease, v. 11, n. 6, p. 547-563, 2009.
[14] HUANG, R., QUAN, Y., HUANG, A., MIN, Z. “Role of Osteopontin in the Carcinogenesis and Metastasis of Colorectal Cancer”. Journal of Cancer Therapy, v. 7, 729-740, 2016.
[15] INCA - Instituto Nacional de Câncer (Brasil). “Estimativa 2018: Incidência de câncer no Brasil”. Available in: URL:http://www.inca.gov.br/estimativa/2018.
[16] LAKEN, S.; GRUBER,S.; PETERSEN, G.; KINZLER, K.; VOGELSTEIN, B. “APC mutation associated with familial colorectal cancer in Ashkenazi Jews”. Universidade Johns Hopkins, Baltimore, Maryland, Estados Unidos. 2000.
[17] PANTANO, E.; PRIPORAS, C. V.; SORACE, S.; IAZZOLINO, G. “Does innovation-orientation lead to retail industry growth? Empirical evidence from patent analysis”. Journal of Retailing and Consumer Services, 34, 88–94. 2017.
[18] SANDLER, Robert S. “Epidemiology and risk factors for colorectal cancer”. Gastroenterology clinics”, v. 25, n. 4, p. 717-735, 1996.
[19] WALTER, V. et al. “Smoking and survival of colorectal cancer patients: systematic review and meta-analysis”. Annals of Oncology, v. 25, n. 8, p. 1517-1525, 2014.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Tiane Camargo, Mariane Camargo Priesnitz, Luciana Maria Fontanari Krause , Marina Bezerra da Silva
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
